SP100 Antibody - #DF4247
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF4247, RRID:AB_2836598.
折りたたみ/展開
DKFZp686E07254; FLJ00340; FLJ34579; Lysp100b; Nuclear antigen Sp100; Nuclear autoantigen Sp 100; Nuclear autoantigen Sp-100; Nuclear autoantigen Sp100; Nuclear dot associated Sp100 protein; Nuclear dot-associated Sp100 protein; SP 100; SP100; SP100 HMG nuclear autoantigen; SP100 nuclear antigen; SP100_HUMAN; Speckled 100 kDa;
免疫原
Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.
- P23497 SP100_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAGGGGDLSTRRLNECISPVANEMNHLPAHSHDLQRMFTEDQGVDDRLLYDIVFKHFKRNKVEISNAIKKTFPFLEGLRDRDLITNKMFEDSQDSCRNLVPVQRVVYNVLSELEKTFNLPVLEALFSDVNMQEYPDLIHIYKGFENVIHDKLPLQESEEEEREERSGLQLSLEQGTGENSFRSLTWPPSGSPSHAGTTPPENGLSEHPCETEQINAKRKDTTSDKDDSLGSQQTNEQCAQKAEPTESCEQIAVQVNNGDAGREMPCPLPCDEESPEAELHNHGIQINSCSVRLVDIKKEKPFSNSKVECQAQARTHHNQASDIIVISSEDSEGSTDVDEPLEVFISAPRSEPVINNDNPLESNDEKEGQEATCSRPQIVPEPMDFRKLSTFRESFKKRVIGQDHDFSESSEEEAPAEASSGALRSKHGEKAPMTSRSTSTWRIPSRKRRFSSSDFSDLSNGEELQETCSSSLRRGSGSQPQEPENKKCSCVMCFPKGVPRSQEARTESSQASDMMDTMDVENNSTLEKHSGKRRKKRRHRSKVNGLQRGRKKDRPRKHLTLNNKVQKKRWQQRGRKANTRPLKRRRKRGPRIPKDENINFKQSELPVTCGEVKGTLYKERFKQGTSKKCIQSEDKKWFTPREFEIEGDRGASKNWKLSIRCGGYTLKVLMENKFLPEPPSTRKKRILESHNNTLVDPCEEHKKKNPDASVKFSEFLKKCSETWKTIFAKEKGKFEDMAKADKAHYEREMKTYIPPKGEKKKKFKDPNAPKRPPLAFFLFCSEYRPKIKGEHPGLSIDDVVKKLAGMWNNTAAADKQFYEKKAAKLKEKYKKDIAAYRAKGKPNSAKKRVVKAEKSKKKKEEEEDEEDEQEEENEEDDDK
PTMs - P23497 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
S18 | Phosphorylation | Uniprot | |
T39 | Phosphorylation | Uniprot | |
Y50 | Phosphorylation | Uniprot | |
K55 | Ubiquitination | Uniprot | |
S65 | Phosphorylation | Uniprot | |
K70 | Ubiquitination | Uniprot | |
K87 | Ubiquitination | Uniprot | |
S92 | Phosphorylation | Uniprot | |
S111 | Phosphorylation | Uniprot | |
K151 | Ubiquitination | Uniprot | |
S157 | Phosphorylation | Uniprot | |
S166 | Phosphorylation | Uniprot | |
S171 | Phosphorylation | Uniprot | |
T176 | Phosphorylation | Uniprot | |
S180 | Phosphorylation | Uniprot | |
S189 | Phosphorylation | Uniprot | |
S191 | Phosphorylation | Uniprot | |
T197 | Phosphorylation | Uniprot | |
T198 | Phosphorylation | Uniprot | |
K217 | Ubiquitination | Uniprot | |
K219 | Ubiquitination | Uniprot | |
T221 | Phosphorylation | Uniprot | |
T222 | Phosphorylation | Uniprot | |
S223 | Phosphorylation | Uniprot | |
K225 | Ubiquitination | Uniprot | |
S228 | Phosphorylation | Uniprot | |
S231 | Phosphorylation | Uniprot | |
T234 | Phosphorylation | Uniprot | |
S247 | Phosphorylation | Uniprot | |
S274 | Phosphorylation | Uniprot | |
K297 | Sumoylation | Uniprot | |
K298 | Ubiquitination | Uniprot | |
K300 | Acetylation | Uniprot | |
K300 | Ubiquitination | Uniprot | |
K306 | Acetylation | Uniprot | |
K306 | Sumoylation | Uniprot | |
K306 | Ubiquitination | Uniprot | |
S327 | Phosphorylation | Uniprot | |
S328 | Phosphorylation | Uniprot | |
S331 | Phosphorylation | Uniprot | |
S334 | Phosphorylation | Uniprot | |
T335 | Phosphorylation | Uniprot | |
S350 | Phosphorylation | Uniprot | |
S362 | Phosphorylation | Uniprot | |
K366 | Sumoylation | Uniprot | |
K366 | Ubiquitination | Uniprot | |
K387 | Sumoylation | Uniprot | |
S389 | Phosphorylation | Uniprot | |
S394 | Phosphorylation | Uniprot | |
K396 | Sumoylation | Uniprot | |
S407 | Phosphorylation | Uniprot | |
S409 | Phosphorylation | Uniprot | |
S410 | Phosphorylation | Uniprot | |
S419 | Phosphorylation | Uniprot | |
K430 | Acetylation | Uniprot | |
K430 | Ubiquitination | Uniprot | |
S445 | Phosphorylation | Uniprot | |
S451 | Phosphorylation | Uniprot | |
S452 | Phosphorylation | Uniprot | |
S453 | Phosphorylation | Uniprot | |
S456 | Phosphorylation | Uniprot | |
S459 | Phosphorylation | Uniprot | |
S476 | Phosphorylation | Uniprot | |
K486 | Acetylation | Uniprot | |
S512 | Phosphorylation | Uniprot | |
S524 | Phosphorylation | Uniprot | |
T525 | Phosphorylation | Uniprot | |
S530 | Phosphorylation | Uniprot | |
K557 | Ubiquitination | Uniprot | |
T560 | Phosphorylation | Uniprot | |
K564 | Ubiquitination | Uniprot | |
K594 | Ubiquitination | Uniprot | |
K601 | Ubiquitination | Uniprot | |
K613 | Ubiquitination | Uniprot | |
K673 | Ubiquitination | Uniprot | |
K731 | Acetylation | Uniprot | |
K733 | Acetylation | Uniprot | |
K733 | Methylation | Uniprot | |
K733 | Ubiquitination | Uniprot | |
K739 | Acetylation | Uniprot | |
K739 | Ubiquitination | Uniprot | |
K750 | Ubiquitination | Uniprot | |
T751 | Phosphorylation | Uniprot | |
Y752 | Phosphorylation | Uniprot | |
K764 | Acetylation | Uniprot | |
K764 | Ubiquitination | Uniprot | |
K786 | Ubiquitination | Uniprot | |
Y818 | Phosphorylation | Uniprot | |
Y836 | Phosphorylation | Uniprot |
研究背景
Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation.
Sumoylated. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting.
Sumoylated. Sumoylated with SUMO1. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting. Sumoylation may stabilize the interaction with CBX5.
Nucleus. Nucleus>PML body. Cytoplasm.
Note: Differences in the subnuclear localization of the different isoforms seem to exist and may also be cell cycle- and interferon-dependent. Accumulates in the cytoplasm upon FAS activation.
Nucleus.
Note: Forms a reticulate or track-like nuclear pattern with denser concentrations at the nuclear lamina and surrounding the nucleoli, a pattern reminiscent of heterochromatin-rich regions according to PubMed:11313457.
Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.
Homodimer; isoforms are able to heterodimerize. Interacts with members of the HP1 family of nonhistone chromosomal protein, such as CBX5 and CBX3 via the PxVxL motif. Interacts with ETS1; the interaction is direct and modulates ETS1 transcriptional activity. Interacts with the MRN complex which is composed of two heterodimers RAD50/MRE11 associated with a single NBN; recruits the complex to PML-related bodies. Interacts with HIPK2; positively regulates TP53-dependent transcription. Interacts with CASP8AP2; may negatively regulate CASP8AP2 export from the nucleus to the cytoplasm. Interacts with SUMO1P1/SUMO5.
(Microbial infection) Interacts with Epstein-Barr virus EBNA-LP; this interaction is important for EBNA-LP coactivator activity.
(Microbial infection) Interacts with human cytomegalovirus/HHV-5 protein UL123; may play a role in infection by the virus.
The HSR domain is important for the nuclear body targeting as well as for the dimerization.
Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain.
研究領域
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.